Vascular endothelial growth factor family of ligands and receptors ZK Otrock, JA Makarem, AI Shamseddine Blood Cells, Molecules, and Diseases 38 (3), 258-268, 2007 | 657 | 2007 |
Understanding the biology of angiogenesis: review of the most important molecular mechanisms ZK Otrock, RAR Mahfouz, JA Makarem, AI Shamseddine Blood Cells, Molecules, and Diseases 39 (2), 212-220, 2007 | 652 | 2007 |
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer D Farge, C Frere, JM Connors, C Ay, AA Khorana, A Munoz, B Brenner, ... The Lancet Oncology 20 (10), e566-e581, 2019 | 445 | 2019 |
Trends in epidemiology and management of breast cancer in developing Arab countries: a literature and registry analysis NS El Saghir, MK Khalil, T Eid, AR El Kinge, M Charafeddine, F Geara, ... International journal of surgery 5 (4), 225-233, 2007 | 443 | 2007 |
Secondary bile acids: an underrecognized cause of colon cancer H Ajouz, D Mukherji, A Shamseddine World journal of surgical oncology 12, 1-5, 2014 | 406 | 2014 |
Effects of young age at presentation on survival in breast cancer NS El Saghir, M Seoud, MK Khalil, M Charafeddine, ZK Salem, FB Geara, ... BMC cancer 6, 1-8, 2006 | 375 | 2006 |
Resistance mechanisms to anti-angiogenic therapies in cancer Y Haibe, M Kreidieh, H El Hajj, I Khalifeh, D Mukherji, S Temraz, ... Frontiers in oncology 10, 221, 2020 | 252 | 2020 |
Appendiceal mucinous neoplasms: diagnosis and management WL Shaib, R Assi, A Shamseddine, OB Alese, C Staley III, B Memis, ... The oncologist 22 (9), 1107-1116, 2017 | 195 | 2017 |
Breast cancer in low-and middle-income countries: an emerging and challenging epidemic A Tfayli, S Temraz, R Abou Mrad, A Shamseddine Journal of oncology 2010, 2010 | 185 | 2010 |
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19 D Farge, C Frere, JM Connors, AA Khorana, A Kakkar, C Ay, A Muñoz, ... The Lancet Oncology 23 (7), e334-e347, 2022 | 175 | 2022 |
Cancer trends in Lebanon: a review of incidence rates for the period of 2003–2008 and projections until 2018 A Shamseddine, A Saleh, M Charafeddine, M Seoud, D Mukherji, ... Population health metrics 12, 1-8, 2014 | 163 | 2014 |
Update on totally implantable venous access devices A Zaghal, M Khalife, D Mukherji, N El Majzoub, A Shamseddine, ... Surgical oncology 21 (3), 207-215, 2012 | 126 | 2012 |
Gut microbiome: a promising biomarker for immunotherapy in colorectal cancer S Temraz, F Nassar, R Nasr, M Charafeddine, D Mukherji, ... International journal of molecular sciences 20 (17), 4155, 2019 | 115 | 2019 |
Dual inhibition of MEK and PI3K pathway in KRAS and BRAF mutated colorectal cancers S Temraz, D Mukherji, A Shamseddine International journal of molecular sciences 16 (9), 22976-22988, 2015 | 115 | 2015 |
Expression, prognostic and predictive impact of VEGF and bFGF in non-small cell lung cancer FS Farhat, A Tfayli, N Fakhruddin, R Mahfouz, ZK Otrock, RS Alameddine, ... Critical reviews in oncology/hematology 84 (2), 149-160, 2012 | 102 | 2012 |
Pamidronate in the prevention of chemotherapy-induced bone loss in premenopausal women with breast cancer: a randomized controlled trial GEH Fuleihan, M Salamoun, YA Mourad, A Chehal, Z Salem, Z Mahfoud, ... The Journal of Clinical Endocrinology & Metabolism 90 (6), 3209-3214, 2005 | 102 | 2005 |
Hypoxia-inducible factor in cancer angiogenesis: structure, regulation and clinical perspectives ZK Otrock, HA Hatoum, AH Awada, RS Ishak, AI Shamseddine Critical reviews in oncology/hematology 70 (2), 93-102, 2009 | 101 | 2009 |
Cancer incidence in postwar Lebanon: findings from the first national population-based registry, 1998 A Shamseddine, AM Sibai, N Gehchan, B Rahal, N El-Saghir, M Ghosn, ... Annals of epidemiology 14 (9), 663-668, 2004 | 99 | 2004 |
Profile of cancer in the Eastern Mediterranean region: The need for action I Kulhánová, F Bray, I Fadhil, AS Al-Zahrani, A El-Basmy, WA Anwar, ... Cancer epidemiology 47, 125-132, 2017 | 96 | 2017 |
Incidence and prophylaxis of venous thromboembolic events in multiple myeloma patients receiving immunomodulatory therapy KM Musallam, FS Dahdaleh, AI Shamseddine, AT Taher Thrombosis research 123 (5), 679-686, 2009 | 91 | 2009 |